The largest database of trusted experimental protocols

7 protocols using activated β catenin

1

Immunohistochemical Analysis of Bone Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sagittal serial sections were stained utilizing primary antibodies directed to mouse Sost (R&D Systems, Minneapolis, MN, USA; AF1589 [1 µg/mL]), human SOST (Abcam, Cambridge, MA, USA; ab75914 [100 µg/mL]), Collagen II (Abcam; ab21291 [1:50]), activated β‐catenin (Millipore, Billerica, MA, USA; 05‐665 [10 µg/mL]), MMP 2 (Abcam; ab110186 [5 µg/mL]), MMP 3 (Abcam; ab52915 [7.04 µg/mL]), MMP9 (Abcam; ab137867 [10.22 µg/mL]), MMP14 (Abcam; ab53712 [10 µg/mL]), and Furin (Abcam; ab3467 [20 µg/mL]). Trypsin/EDTA was used for antigen retrieval in 37°C for 30 minutes for all primary antibody except for activated β‐catenin and MMPs 2, 3, 9, and Furin, which required Uni‐trieve (Innovex Biosciences, Richmond, CA, USA) in 65°C for 30 minutes. After Uni‐trieve, activated β‐catenin and Furin require an additional retrieval with Proteinase K (Ambion, Austin, TX, USA; AM2546 [20 µg/mL]) for 20 minutes. This was followed by using Alexa‐Fluor 488 (green) or 594 (red) (Molecular Probes, Eugene, OR, USA) to determine protein expression.
+ Open protocol
+ Expand
2

Western Blot Analysis of β-Catenin

Check if the same lab product or an alternative is used in the 5 most similar protocols
Protein lysates were obtained from isolated GFP+ cells or cultured CFs. Standard western blots were performed. Briefly, 15–30 μg of protein was separated by 10–15% SDS-PAGE gel and transferred to PVDF membranes. After blocking in Odyssey blocking buffer (LI-COR, P/N 927-40000), blots were probed with primary antibodies: activated β-catenin (1:500, Millipore, #05-665), total β-catenin (1:1000, Cell signaling, #9581 S), and GAPDH (1:10 000; Santa Cruz Biotechnology #25778). After incubation with corresponding anti-mouse/rabbit secondary antibodies (1:10 000; LI-COR), immunoblots were developed using ODYSSEY Infrared Imaging System (LI-COR). Signal intensities were quantified with ImageStudio software (LI-COR). GAPDH was used as a loading control. Uncropped images of western blots are included in Supplementary Fig. 9.
+ Open protocol
+ Expand
3

Quantitative Western Blotting Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Western blotting was performed as previously described (Merino et al., 2016) using antibodies to phosphorylated AKT‐Ser (#4058S), phosphorylated GSK3‐β (#9323P), and phosphorylated STAT3 (#9131) from Cell Signaling, Danvers, MA, USA; activated β‐catenin (#05665), STAT3 (#06596), and GAPDH (#MAB374) from Millipore, Billerica, MA, USA; β‐catenin (#138400) and cyclin D1 (#AHF0102) from ThermoFisher Scientific.
+ Open protocol
+ Expand
4

Immunohistochemical Analysis of Cell Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunohistochemical staining was performed according to a previously established protocol28 (link). Primary antibodies against ACTA2 (Sigma-Aldrich, St. Louis, MO, USA), VIM (Santa Cruz Biotechnology, California, USA), FSP-1 (Thermo Scientific, Fremont, CA, USA), PCNA (Dako, Glostrup, Denmark), activated β-catenin (Sigma-Aldrich), and TAZ (Santa Cruz Biotechnology, Santa Cruz, CA, USA) were used. TUNEL staining was performed using a commercial kit (Millipore, Billerica, MA, USA), in accordance with the manufacturer’s instructions.
+ Open protocol
+ Expand
5

Western Blot Analysis of Protein Targets

Check if the same lab product or an alternative is used in the 5 most similar protocols
The total proteins isolated from cells or tissue samples and protein concentration were measured by DC Protein Assay (Bio-Rad Laboratories). 10 µg of proteins from each sample were separated on 10% SDS–PAGE and then transferred onto PVDF membranes. After blocking with 5% bovine serum albumin, blots were incubated with primary antibodies overnight at 4 °C. The primary antibodies used are as follows: activated β-catenin (05-665, Sigma), Cyclin D1 (#2922 S, Cell Signaling Technology), β-Actin (#4970, Cell Signaling Technology). Membranes were then incubated with secondary antibodies for 1 h at room temperature. Membranes were exposed to Pierce ECL Western Blotting Substrate (GE Healthcare). Band intensities were determined using ImageJ (National Institutes of Health).
+ Open protocol
+ Expand
6

Immunohistochemistry of Brain Sections

Check if the same lab product or an alternative is used in the 5 most similar protocols
Brain sections were incubated with primary antibodies overnight, followed by appropriate fluorescently conjugated secondary antibodies and counterstained with 4′,6-diamidino-2-phenylindole (DAPI; Sigma-Aldrich, D9542). Primary antibodies used were against BrdU (1:500; Abcam, ab6326), GFP (1:1000; Aves Lab, GFP-1020), Ki67 (1:300; Abcam, ab15580), phosphohistone H3 (1:1000; Upstate, 06-570), Tbr1 (1:500; Abcam, ab31940), Tbr2 (1:500; Millipore, ab31940), Par3 (1:500; Millipore, MABF28), Pax6 (1:500; Millipore, AB2237), anti-NeuN (1:1000; Millipore, ABN78), Cux1 (1:500; Santa Cruz Biotechnology), and activated β-catenin (1:500; Merck, 05-665). Secondary antibodies were from Vector Lab [biotinylated anti-rat immunoglobulin G (IgG; 1:200; BA-9400) and biotinylated anti-rabbit IgG (1:200; BA-1000)], from Jackson ImmunoResearch [Cy3 Fab fragment anti-rabbit IgG (1:200; 711-167-003), Alexa Fluor 488 anti-chicken IgY (1:200; 703-545-155), and Cy5 streptavidin (1:200; 016-170-084)], and from Invitrogen [Alexa Fluor 555 anti-rabbit IgG (1:200; A-31572)].
+ Open protocol
+ Expand
7

Immunofluorescence Staining of Intestinal Crypts

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunofluorescence staining was conducted as described by Mahe et al. (23 (link)). After collection medium was removed, crypts were fixed with 4% paraformaldehyde and permeabilized with Triton X-100 (0.1% in PBS). They were washed with PBS before fixation and again before permeabilization. After permeabilization, crypts were blocked with blocking buffer (1% BSA, 3% normal goat serum, and 0.2% Triton X-100 in PBS) and incubated with antibodies for BMI1 (Miltenyi), β-catenin (Miltenyi), activated β-catenin (EMD Millipore), CD24 (BioLegend), CD44 (Tonbo), CD66a (eBioscience), LGR5 (Miltenyi and Origene), or LRIG1 (R&D) (Table 2) in working buffer (0.1% BSA, 0.3% normal goat serum, and 0.2% Triton X-100 in PBS) before mounting (Fluoromount-G, SouthernBiotech) for observation. Crypts were washed with PBS before blocking, incubation, and mounting. Justification for specific antibodies used is provided in the Supplementary Methods (see Supplementary Digital Content 1, http://links.lww.com/CTG/A612). Note that 2 separate LGR5 antibodies were tested for immunofluorescence.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!